Important information regarding delivery times:
Due to the annual closing of the tissue bank C+TBA and the partner company for irradiation for Christmas from 21.12.2020 – 08.01.2021, the lead time will be longer than usual.
The estimated delivery date will be communicated separately for every individual order. We apologize for any inconveniences.
Your maxgraft® bonebuilder team
maxgraft® bonebuilder
CUSTOMIZED ALLOGENIC BONE BLOCK FOR TWO-STAGE ALVEOLAR RIDGE AUGMENTATION
Based on CT/CBCT scans of the patient, the bone block is virtually designed using the latest 3D CAD/CAM (computer-aided design/computer-aided manufacturing) technology.
maxgraft® bonebuilder offers greater precision and accuracy of fit compared to classical block augmentation. Manual adjustment of the block during the operation is seldom required and maxgraft® bonebuilder may be applied directly onto the defect, reducing surgery time as well as risk of infection.1,2 The individual design provides a precise fit between local bone and the allogenic bone block, enabling rapid revascularization and fast graft incorporation.
PLANNING & PRODUCTION
maxgraft® bonebuilder is planned in close interaction between clinical users and botiss CAD-designers with multiple feedback loops to ensure an optimal fit. Communication is mainly done via email using the comment section on the specific order web page.
STEP BY STEP
1. Data upload
2. Block design
3. Design check of the 3D-planning
4. Order of maxgraft® bonebuilder
5. Production
6. Invoice and delivery
THE ORIGIN
maxgraft®
SAFE, RELIABLE AND PREDICTABLE CLINICAL OUTCOME
maxgraft® bonebuilder is produced at the Cells+Tissuebank Austria (C+TBA), a non-profit organization aiming to provide allogenic transplants for orthopedic and dental regeneration situated in Krems/Austria.
maxgraft® bonebuilder is 100% human donor bone and originates from femoral heads (taken during hip endoprosthesis surgery) of living donors from certified procurement centers in Europe.
The ALLOTEC® Process
The Allotec® process, a gentle process with volatile agents only, has been proven to eliminate potential pathogens, without destroying the natural bone structure. Thus, C+TBA allografts exhibit excellent biocompatibility and outstanding handling properties without even a suspected case of disease transmission.
See publications, case reports and clinical cases
PROPERTIES
+ Processed human allograft from selected living donors, undergoing a hip replacement (Production: C+TBA, Krems, Austria)
+ Natural mineralized collagen
+ Maximum size: 23 x 13 x 13 mm
+ Fast graft incorporation and complete remodeling potential
+ No donor site morbidity
+ 5-6 months healing-/integration time
+ 5 years shelf life at room temperature
See education, webinars and surgeries
References
1 Jacotti et al. 2014. Posterior atrophic mandible rehabilitation with onlay allograft created with CAD-CAM procedure: a case report. Implant Dent. 23(1):22–8.
2 Blume, O. et al. 2017. Treatment of Severely Resorbed Maxilla Due to Peri-Implantitis by Guided Bone Regeneration Using a Customized Allogenic Bone Block: A Case Report. Materials 10(10): 1213.
3 McAllister, B.S. et al 2007. Bone augmentation techniques. Journal of Periodontology, 78:377-396.